For those aiming to surpass market returns, the art of stock picking is crucial. Making wise choices in stocks can greatly enhance your overall wealth.
As of close of business last night, Inspire Medical Systems Inc’s stock clocked out at $225.22, down -1.75% from its previous closing price of $229.22. In other words, the price has decreased by $-1.75 from its previous closing price. On the day, 0.59 million shares were traded. INSP stock price reached its highest trading level at $231.025 during the session, while it also had its lowest trading level at $220.24.
Ratios:
To gain a deeper understanding of INSP’s stock, we examine its different ratios. It provided that stocks Price–to–Cash (P/C) ratio for the trailing twelve months (TTM) is standing at 14.82 whereas its Price-to-Free Cash Flow (P/FCF) for the term is 6690.36. For the most recent quarter (mrq), Quick Ratio is recorded 7.17 and its Current Ratio is at 7.60. In the meantime, Its Debt-to-Equity ratio is 0.04 whereas as Long-Term Debt/Eq ratio is at 0.04.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for this company, RBC Capital Mkts on April 19, 2024, initiated with a Outperform rating and assigned the stock a target price of $285.
On March 19, 2024, Morgan Stanley started tracking the stock assigning a Overweight rating and target price of $250.
Insider Transactions:
Investing in insider trades can also provide an investor with insight into how management views future stock prices. A recent insider transaction in this stock occurred on Apr 17 ’24 when Buchholz Richard sold 15,000 shares for $230.03 per share. The transaction valued at 3,450,450 led to the insider holds 28,271 shares of the business.
Herbert Timothy P. sold 40,000 shares of INSP for $8,203,581 on Apr 01 ’24. The CEO and President now owns 63,658 shares after completing the transaction at $205.09 per share. On Apr 01 ’24, another insider, Griffin Jerry C, who serves as the Director of the company, sold 32 shares for $213.99 each. As a result, the insider received 6,848 and left with 10,900 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, INSP now has a Market Capitalization of 6823558144 and an Enterprise Value of 6227628032. For the stock, the TTM Price-to-Sale (P/S) ratio is 10.92 while its Price-to-Book (P/B) ratio in mrq is 11.63. Its current Enterprise Value per Revenue stands at 9.967 whereas that against EBITDA is -166.403.
Stock Price History:
The Beta on a monthly basis for INSP is 1.35, which has changed by -0.1548968 over the last 52 weeks, in comparison to a change of 0.23061275 over the same period for the S&P500. Over the past 52 weeks, INSP has reached a high of $330.00, while it has fallen to a 52-week low of $123.27. The 50-Day Moving Average of the stock is 10.76%, while the 200-Day Moving Average is calculated to be 10.37%.
Shares Statistics:
It appears that INSP traded 510.11K shares on average per day over the past three months and 656500 shares per day over the past ten days. A total of 30.30M shares are outstanding, with a floating share count of 29.66M. Insiders hold about 2.09% of the company’s shares, while institutions hold 102.54% stake in the company. Shares short for INSP as of 1711584000 were 2079086 with a Short Ratio of 4.08, compared to 1709164800 on 1748508. Therefore, it implies a Short% of Shares Outstanding of 2079086 and a Short% of Float of 7.8600004000000006.
Earnings Estimates
The current assessment of Inspire Medical Systems Inc (INSP) involves the perspectives of 17 analysts closely monitoring its market dynamics.On average, analysts expect EPS of $-0.65 for the current quarter, with a high estimate of $-0.41 and a low estimate of $-0.85, while EPS last year was $-0.53. The consensus estimate for the next quarter is $-0.23, with high estimates of $-0.06 and low estimates of $-0.5.
Analysts are recommending an EPS of between $0.21 and $-1.17 for the fiscal current year, implying an average EPS of $-0.36. EPS for the following year is $0.62, with 18 analysts recommending between $2.41 and $-0.33.
Revenue Estimates
In the current quarter, 17 analysts expect revenue to total $161.44M. It ranges from a high estimate of $163.9M to a low estimate of $159.7M. As of the current estimate, Inspire Medical Systems Inc’s year-ago sales were $127.9M, an estimated increase of 26.20% from the year-ago figure.
A total of 18 analysts have provided revenue estimates for INSP’s current fiscal year. The highest revenue estimate was $796.1M, while the lowest revenue estimate was $775M, resulting in an average revenue estimate of $782.26M. In the same quarter a year ago, actual revenue was $624.8M, up 25.20% from the average estimate. Based on 18 analysts’ estimates, the company’s revenue will be $950.97M in the next fiscal year. The high estimate is $996.85M and the low estimate is $899.59M. The average revenue growth estimate for next year is up 21.60% from the average revenue estimate for this year.
